Optimization of Lipid Nanoparticle Analysis Across Near-Universal Detectors

Significance of the topic

The analytical characterization of lipid nanoparticles (LNPs) is critical for development, quality control, and regulatory submission of mRNA therapeutics and vaccines. LNP formulations rely on carefully controlled molar ratios of phospholipid, ionizable lipid, PEG-lipid, and cholesterol to ensure correct particle size, stability, and delivery performance. Many lipid components lack strong UV chromophores, so near-universal detectors that respond to nonvolatile analytes are required to achieve reliable quantitation across a full lipid panel.

Objectives and study overview

This application study compared two commonly used near-universal aerosol detectors—charged aerosol detection (CAD) and evaporative light scattering detection (ELSD)—for quantitative analysis of a representative four‑component LNP formulation. Goals were to evaluate and compare limits of quantitation (LOQ), linearity, repeatability at LOQ, chromatographic resolution of a critical lipid pair (DSPC/SM‑102), and sample recovery when using otherwise identical chromatographic conditions on the same UPLC platform.

Methodology

The study prepared individual stock solutions of four typical LNP lipids (SM‑102, cholesterol, DSPC, DSPE‑PEG 2000) at 2 mg/g in methanol and prepared standards from 5 to 500 µg/g. Representative sample mixtures were prepared at a target formulation ratio (SM‑102:cholesterol:DSPC:DSPE‑PEG 2000 = 50:38.5:10:1.5) at two overall concentration levels to evaluate detection at low and high sample loads. The same chromatographic method was developed on an ACQUITY Premier UPLC system and first optimized with CAD, then transferred to ELSD with detector‑specific optimization while keeping LC hardware, column, and gradient constant. Log–log linear regression (power‑law fit) was used for calibration because both detectors display inherent nonlinearity across wide concentration ranges.

Used instrumentation

• UPLC: ACQUITY Premier UPLC System
• Detectors: Charged Aerosol Detector (CAD) and Evaporative Light Scattering Detector (ELSD)
• Column: CORTECS Phenyl, 90 Å, 1.6 µm, 2.1 × 100 mm
• Mobile phases: 10 mM ammonium acetate in 90/10 methanol/water (A) and 10 mM ammonium acetate in 90/10 acetonitrile/water (B)
• Flow rate: 0.400 mL/min; injection volume: 5 µL; column temp: 30 °C; sample temp: 12 °C
• CAD settings: power function = 1; evaporator temp = 40 °C
• ELSD settings optimized: cooling nebulizer mode, drift tube 50 °C, gas pressure 40 psi, gain 125

Main results and discussion

• LOQ: CAD delivered a uniform LOQ of 5 µg/g for all four lipid components. ELSD required higher LOQs (10–15 µg/g) driven principally by low response and repeatability for the low‑abundance PEG‑lipid (DSPE‑PEG 2000), which limited the usable sample concentration for the whole formulation.
• Chromatographic resolution: Under CAD detection the critical pair DSPC and SM‑102 was baseline resolved (USP R ≈ 2.5) at the lower sample load. ELSD required higher sample concentration to meet signal requirements, which led to decreased resolution and partial co‑elution of that critical pair.
• Linearity: Log–log calibration from LOQ to 500 µg/g produced strong fits on both detectors. CAD achieved higher coefficients of determination (R2 ≥ 0.998 for all analytes) while ELSD R2 values were ≥ 0.994 but consistently lower than CAD.
• Repeatability at LOQ: Area %RSD values at LOQ were substantially better on CAD (all ≤ 6%) versus ELSD (higher RSDs; for cholesterol and SM‑102 CAD RSDs were ~4× lower than ELSD). CAD therefore showed superior precision at low analyte levels.
• Recovery and accuracy: Sample recoveries calculated from calibrated curves were tighter and closer to 100% on CAD (range ~93.8–105.8%) compared with ELSD (range ~79.8–137.2%), indicating improved quantitative accuracy and robustness with CAD under the studied conditions.
• Detection physics driving differences: CAD measures charged aerosol current and depends on the particle charge‑to‑size relationship; ELSD measures light scattering and depends on particle size and refractive index. These differing mechanisms explain the relative sensitivity, dynamic behavior, and stability differences observed for certain lipids—particularly low‑concentration PEG‑lipids.

Practical benefits and applications

• CAD enables lower LOQs, superior precision at low concentrations, and improved chromatographic resolution for critical lipid pairs—benefits that support sensitive potency, formulation control, and QC release testing of LNP products.
• Improved recovery and narrower quantitation windows on CAD reduce uncertainty in stability studies, process development, and batch comparability assessments.
• Because both detectors require log–log calibration, routine implementation should include appropriate calibration ranges, QC checks, and system suitability criteria tailored to the chosen detector.

Future trends and possibilities for use

• Broader lipid panels and more complex matrices: Extend comparative work to diverse PEG‑lipids, ionizable lipid classes, and impurity profiling to define generalizable detector selection criteria.
• Hybrid workflows: Combine CAD quantitation for routine lipid assays with orthogonal methods (e.g., MS for identity and structural confirmation) to marry universality and specificity.
• Automation and robustness: Implement autosampler workflows, automated system suitability, and stability‑indicating stress studies to further demonstrate CAD suitability for regulated QC environments.
• Detector improvements: Continued development in detector design and signal processing may expand linear dynamic range and lower noise for ELSD and CAD alike; benchmarking newer near‑universal detectors against CAD will remain important.
• Method transfer and standardization: Establish robust method transfer protocols (including power‑law calibration acceptance criteria) between labs and instruments to ensure reproducibility in regulated submissions.

Conclusion

In this comparative evaluation, CAD provided clear analytical advantages for the tested LNP formulation: lower limits of quantitation (5 µg/g for all four lipids), improved repeatability and accuracy at low concentrations, higher calibration linearity across a wide range, and maintained chromatographic resolution of a critical lipid pair. ELSD can still be effective for some lipids but required higher concentrations and showed wider variability in recovery and precision for low‑abundance components. For quantitative LNP analysis where sensitivity, precision, and accurate recovery are priorities, CAD is the recommended near‑universal detector under the conditions studied.

References

1. Hou X, Zaks T, Langer R. Lipid Nanoparticles for mRNA delivery. Nature Reviews Materials. 2021;6:1078–1094.
2. Albertsen CH, et al. The Role of Lipid Components in Lipid Nanoparticles for Vaccines and Gene Therapy. Advanced Drug Delivery Reviews. 2022;188:114416.
3. Barnhart WW, Farooq MQ, Ahmad IAH. A Simplified Tutorial on Charged Aerosol Detection: Understanding the Basics, Optimization, and Troubleshooting. Journal of Chromatography Open. 2024;100181.
4. DeLaney K, Han D, Birdsall RE, Yu YQ. Optimized ELSD Workflow for Improved Detection of Lipid Nanoparticle Components. Waters Application Note. 2022.